Santhigram Kerala Ayurvedic CO OF Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Santhigram Kerala Ayurvedic CO OF Pharmaceutical Import Records from India — 2 Products, $11.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Santhigram Kerala Ayurvedic CO OF — Pharmaceutical Importer Profile (2026) | 2 Products, $11.8K Trade | TransData Nexus

Santhigram Kerala Ayurvedic CO OF

Pharmaceutical Importer · United States · Ayurvedic & Herbal Products Focus · $11.8K Total Trade · DGFT Verified

Santhigram Kerala Ayurvedic CO OF is a pharmaceutical importer based in United States with a total trade value of $11.8K across 2 products in 1 therapeutic categories. Based on 16 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Santhigram Kerala Ayurvedic CO OF sources from 1 verified Indian supplier, with Bharath Vaidyasala accounting for 100.0% of imports.

Santhigram Kerala Ayurvedic CO OF — Import Portfolio & Supplier Network

Santhigram Kerala Ayurvedic CO OF import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Santhigram Kerala Ayurvedic CO OF?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Bharath Vaidyasala	$203.8K	672	100.0%

Santhigram Kerala Ayurvedic CO OF sources from 1 verified Indian supplier across 665 distinct formulations. The sourcing is highly concentrated — Bharath Vaidyasala accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ayurvedic product-manasamithra gulika	$6.4K	1
Ayurvedic products - manasamitra	$3.9K	1
Ayurveda products - manasamitra	$3.0K	1
Ayurvedic products - mahatiktaka ghritamsoft gel	$2.7K	1
Ayurvedic products - manasamitra	$2.6K	1
Ayurvedic products - maharajaprasarni soft gel	$2.5K	1
Ayurvedic products - manasamitra	$2.4K	1
Ayurvedic products - guggulutiktaka ghrutham softgel	$2.4K	1
Ayurvedic products - gandhathailam softgel	$2.3K	1
Ayurvedic products - dhanwantaram 101 asoft gel	$2.1K	1
Ayurvedic product-kumkumadi	$2.1K	1
Ayurvedic products - gorochanadi	$2.1K	1
Ayurvedic products - ksheerabala 101 a softgel	$2.1K	1
Ayurvedic products - balathailam soft gel	$2.0K	1
Ayurvedic products - sahacharadi thailamsoftgel	$1.9K	1

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Bhasma	Ayurvedic & Herbal Products	$8.7K	11	2.1%	12
2	Ghrita	Ayurvedic & Herbal Products	$3.1K	5	0.7%	12

Santhigram Kerala Ayurvedic CO OF imports 2 pharmaceutical products across 1 categories into United States totaling $11.8K.

Santhigram Kerala Ayurvedic CO OF — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Santhigram Kerala Ayurvedic Co. of U.S., Inc. is a specialized importer and distributor of Ayurvedic pharmaceutical formulations based in Edison, New Jersey. Established in 1998, the company has expanded its presence across the United States, operating multiple wellness centers that offer authentic Kerala-specific Ayurvedic treatments. These centers provide a range of services, including Panchakarma therapies, holistic health consultations, and Ayurvedic products, aiming to promote overall well-being through traditional healing practices.

In addition to its wellness centers, Santhigram Kerala Ayurvedic Co. of U.S., Inc. engages in the importation of Ayurvedic pharmaceutical formulations from India. The company's import activities are primarily focused on finished pharmaceutical products, such as tablets, capsules, syrups, and injections, rather than raw active pharmaceutical ingredients (APIs) or bulk drugs. This strategic approach allows Santhigram to offer a diverse portfolio of Ayurvedic medicines to the U.S. market, catering to the growing demand for alternative and holistic health solutions.

2Distribution Network

Santhigram Kerala Ayurvedic Co. of U.S., Inc. operates a network of wellness centers across the United States, with locations in New Jersey, New York, Texas, and Illinois. These centers serve as distribution points for the company's Ayurvedic products, ensuring accessibility to a wide customer base. The company's logistics capabilities are tailored to support the distribution of finished pharmaceutical formulations, maintaining product integrity and compliance with U.S. regulatory standards. While specific warehouse locations are not publicly disclosed, the strategic placement of wellness centers facilitates efficient distribution and customer engagement.

3Industry Role

In the U.S. pharmaceutical supply chain, Santhigram Kerala Ayurvedic Co. of U.S., Inc. functions as a specialized distributor and importer of Ayurvedic pharmaceutical formulations. By sourcing finished products from India, the company introduces a unique segment of alternative medicine to the U.S. market, catering to consumers seeking holistic health solutions. This role positions Santhigram as a niche player within the broader pharmaceutical distribution landscape, focusing on Ayurvedic products that are not widely available through conventional pharmaceutical channels.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Santhigram Kerala Ayurvedic CO OF

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Santhigram Kerala Ayurvedic Co. of U.S., Inc. demonstrates a high degree of supplier concentration, with all its imports originating from a single Indian supplier, BHARATH VAIDYASALA. This exclusive sourcing strategy indicates a strong, established relationship between Santhigram and BHARATH VAIDYASALA, potentially ensuring product consistency and quality. However, such dependency also exposes Santhigram to risks associated with supply chain disruptions, regulatory changes, or operational challenges faced by the sole supplier. The stability of this relationship is crucial for maintaining uninterrupted product availability and meeting market demand.

2Supply Chain Resilience

The resilience of Santhigram Kerala Ayurvedic Co. of U.S., Inc.'s supply chain is closely tied to the operational stability of its sole supplier, BHARATH VAIDYASALA. Given the exclusive nature of this partnership, Santhigram's supply chain may be vulnerable to disruptions originating from the supplier's end, such as production delays, quality control issues, or regulatory compliance challenges. To enhance supply chain resilience, it would be prudent for Santhigram to consider diversifying its supplier base and establishing relationships with additional manufacturers of Ayurvedic formulations. This strategy could mitigate risks associated with sole-source dependency and ensure a more robust supply chain capable of adapting to unforeseen challenges.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation and marketing of pharmaceutical products, including Ayurvedic formulations. The Federal Food, Drug, and Cosmetic Act (FD&C Act) establishes the legal framework for drug approval, importation, and distribution. Under this act, all drugs introduced into interstate commerce must be approved by the FDA, ensuring they are safe and effective for their intended use. For Ayurvedic products, this means they must undergo the FDA's new drug application (NDA) process unless they are recognized as generally safe and effective.

2Import Licensing & GMP

Import licensing requirements for Ayurvedic pharmaceutical products in the U.S. are governed by the FDA. Importers must ensure that their products comply with FDA regulations, which may include obtaining an import license and providing evidence of Good Manufacturing Practice (GMP) compliance. The FDA recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers must verify that their suppliers hold valid GMP certifications from these recognized organizations to ensure product quality and regulatory compliance.

Santhigram Kerala Ayurvedic CO OF — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Santhigram Kerala Ayurvedic Co. of U.S., Inc.'s focus on Ayurvedic and herbal products aligns with the growing consumer interest in alternative and holistic health solutions in the United States. The company's importation of Ayurvedic formulations caters to a niche market seeking natural remedies and wellness therapies rooted in traditional Indian medicine. This strategic focus allows Santhigram to differentiate itself in the competitive U.S. pharmaceutical market by offering unique products that appeal to health-conscious consumers.

2Sourcing Profile

Santhigram Kerala Ayurvedic Co. of U.S., Inc. employs a sourcing strategy that emphasizes exclusive partnerships with suppliers of Ayurvedic pharmaceutical formulations. By importing finished products from India, the company ensures a consistent supply of high-quality Ayurvedic medicines that meet U.S. regulatory standards. This approach allows Santhigram to offer a specialized product portfolio, catering to consumers seeking authentic Ayurvedic treatments.

3Market Positioning

Based on its product mix, Santhigram Kerala Ayurvedic Co. of U.S., Inc. serves a segment of the U.S. market that includes retail pharmacies, wellness centers, and consumers seeking alternative health solutions. The company's focus on Ayurvedic pharmaceutical formulations positions it as a niche player within the broader pharmaceutical distribution landscape, appealing to a specific consumer base interested in holistic and natural health products.

Seller's Guide — How to Become a Supplier to Santhigram Kerala Ayurvedic CO OF

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Santhigram Kerala Ayurvedic Co. of U.S., Inc., provided they can meet the company's quality standards and regulatory requirements. Expanding Santhigram's supplier base could lead to a more diversified product portfolio, catering to a broader consumer base seeking Ayurvedic health solutions. For Indian exporters, establishing a relationship with Santhigram offers a pathway to enter the U.S. market, leveraging Santhigram's established distribution network and market presence.

2Requirements & Qualifications

Indian exporters seeking to supply Santhigram Kerala Ayurvedic Co. of U.S., Inc. must ensure their products comply with FDA regulations, including obtaining necessary import licenses and providing evidence of GMP compliance from recognized international bodies such as WHO or PIC/S. Products must undergo batch testing, stability studies, and meet labeling requirements in English, as per FDA guidelines. Additionally, exporters should be prepared to meet serialization mandates to facilitate product tracking and prevent counterfeiting.

3How to Approach

Frequently Asked Questions — Santhigram Kerala Ayurvedic CO OF

What products does Santhigram Kerala Ayurvedic CO OF import from India?

Santhigram Kerala Ayurvedic CO OF imports 2 pharmaceutical products across 1 categories. Top imports: Bhasma ($8.7K), Ghrita ($3.1K).

Who supplies pharmaceuticals to Santhigram Kerala Ayurvedic CO OF from India?

Santhigram Kerala Ayurvedic CO OF sources from 1 verified Indian suppliers. The primary supplier is Bharath Vaidyasala (100.0% of imports, $203.8K).

What is Santhigram Kerala Ayurvedic CO OF's total pharmaceutical import value?

Santhigram Kerala Ayurvedic CO OF's total pharmaceutical import value from India is $11.8K, based on 16 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Santhigram Kerala Ayurvedic CO OF focus on?

Santhigram Kerala Ayurvedic CO OF imports across 1 categories. The largest: Ayurvedic & Herbal Products (100.0%).

Get Full Santhigram Kerala Ayurvedic CO OF Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.